About Otonomy Inc.
Otonomy develops sustained-exposure drug therapies for ear diseases including Meniere disease, hearing loss, and otitis media using novel otic drug delivery formulations.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Otonomy Inc.. Response typically within 48 hours.
Company Info
TypePublic
StockOTIC (NASDAQ)
Founded2008
Employees80
Revenue$12M
HQSan Diego, USA
